BioNTech SECompte certifié

@BioNTech_Group

Our vision is to harness the power of the immune system to develop novel therapies based on groundbreaking R&D with cutting-edge technologies

Mainz, Germany
biontech.de
Inscrit en novembre 2018
94 Photos et vidéos Photos et vidéos

Tweets

Vous avez bloqué @BioNTech_Group

Êtes-vous sûr de vouloir voir ces Tweets ? Les voir ne débloquera pas @BioNTech_Group

  1. 9 sept.

    Science or Art? A new publication about the potential of mRNA as therapeutic option for cancer in . The clinical trial is ongoing.

    8 réponses 23 Retweets 89 j'aime
    Supprimer
  2. 27 août

    Invited by the , President of Rwanda, President of Senegal, & President met CEO Uğur Şahin to discuss the establishment of vaccine manufacturing capabilities in the AU.

    30 réponses 249 Retweets 767 j'aime
    Supprimer
  3. 26 août

    We announced the signing of a letter of intent with Brazilian biopharmaceutical company Eurofarma Laboratórios to manufacture our -19 vaccine for distribution within Latin America. This is an important step to broaden the access to vaccines.

    7 réponses 29 Retweets 180 j'aime
    Supprimer
  4. 23 août

    The approved the Biologics License Application for our vaccine to prevent in individuals 16yrs & older. is the Marketing Authorization Holder in the U.S., making it the 1st COVID-19 vaccine granted approval by the FDA.

    33 réponses 75 Retweets 300 j'aime
    Supprimer
  5. 9 août

    We want to make a difference for individuals and humankind. Our strategy remains focused on bringing our broad pipeline of Next-Generation Immunotherapies and to people worldwide to address and a growing list of infectious diseases:

    25 réponses 20 Retweets 141 j'aime
    Supprimer
  6. 4 août

    Welcoming >50 new colleagues in Gaithersburg, MD! The 3rd acquisition in 14 months confirms our strategy of complementing organic growth through targeted acquisitions that expand our capabilities & accelerate the development of our immunotherapy pipeline.

    18 réponses 15 Retweets 123 j'aime
    Supprimer
  7. 3 août

    “mRNA could be the next revolution in the biopharmaceutical landscape” said one of our co-founders Ugur Sahin and Özlem Türeci who joined for a talk about . Learn more about our technology and what’s next.

    38 réponses 69 Retweets 266 j'aime
    Supprimer
  8. 26 juil.

    We want to help eradicate Malaria. Therefore, we’re launching a project aimed and developing a well-tolerated and highly effective Malaria vaccine and implement sustainable vaccine supply solutions on the African continent.

    24 réponses 104 Retweets 324 j'aime
    Supprimer
  9. 22 juil.

    The recent flood disaster in Germany has a dramatic effect on a large number of people who've lost relatives, friends and homes. In solidarity, we will be donating 1 million € to the German Alliance for Disaster Relief (Aktionsbündnis Katastrophenhilfe).

    22 réponses 63 Retweets 394 j'aime
    Supprimer
  10. 21 juil.

    Our first manufacturing partner within the African Union has just been announced! is a Cape Town based biopharmaceutical company which will support the production of more than 100m doses of our vaccine as well as the distribution.

    15 réponses 136 Retweets 412 j'aime
    Supprimer
  11. 9 juil.

    We want to help to bring this pandemic to an end. In light of the , we have early added a new pillar to our comprehensive booster strategy – keeping us ahead of the COVID-19 virus.

    31 réponses 83 Retweets 260 j'aime
    Supprimer
  12. 23 juin

    Vielen Dank an alle Referent:innen und Teilnehmer:innen des 1. mRNA-Kongresses von BioNTech. Ihre große Begeisterung für das Thema und die Diskussionen zeigen, dass wir gemeinsam auf dem richtigen Weg sind: aus der Pandemie zurück in ein normales Leben.

    21 réponses 16 Retweets 117 j'aime
    Supprimer
  13. 18 juin

    We want to revolutionize cancer treatment and we continue to advance our pipeline: the first patient has been treated in our BNT111 randomized Phase 2 trial. BNT111 is the lead product candidate from our proprietary FixVac platform.

    23 réponses 73 Retweets 328 j'aime
    Supprimer
  14. 17 juin

    We've reached a new milestone: We've manufactured 1bn doses of our based vaccine together with our partner . Our teams go above & beyond every day to bring the vaccine to as many people as possible around the world. Kudos to our colleagues!

    43 réponses 126 Retweets 655 j'aime
    Supprimer
  15. 10 juin

    Exzellenter Auftakt für den -Kongress am 12. Juni: Die Eröffnungskeynote hält Dr. Özlem Türeci Mitgründerin und CMO von . Jetzt anmelden unter: . Die Teilnahme ist für alle.

    24 réponses 15 Retweets 87 j'aime
    Supprimer
  16. 10 juin

    Addressing a pandemic requires global collaboration. As part of our pledge of 2bn doses to broaden access to our vaccine, we’re providing 500m doses at a not-for profit price to the US for donation to ≈100 low- & lower middle-income countries.

    8 réponses 37 Retweets 202 j'aime
    Supprimer
  17. 31 mai

    The expanded the conditional marketing authorization for our vaccine to incl. individuals 12-15rys of age. Our pediatric studies evaluating the safety & efficacy of our vaccine in children from the ages of 6mths - 11yrs are ongoing.

    33 réponses 83 Retweets 249 j'aime
    Supprimer
  18. a retweeté
    21 mai

    We are working closely with our industrial partners to supply vaccines to low & middle income countries. They just pledged to make available 1.3 billion doses to these countries in 2021. 1 billion from 200 million from 100m from

    76 réponses 185 Retweets 639 j'aime
    Supprimer
  19. 21 mai

    We have published our first Sustainability Report. The publication is a milestone for us, showcasing not only the contribution we aspire to make to society through our innovative research, but also the wider responsibility we take on as a company.

    30 réponses 6 Retweets 107 j'aime
    Supprimer
  20. a retweeté
    20 mai

    Our new 🇪🇺 contract 2021-2023 with is now signed. It guarantees up to 1.8 billion doses for our fight against COVID and its variants. Contracts with other companies may follow, to protect Europe and the world in the long term.

    154 réponses 431 Retweets 1 682 j'aime
    Supprimer

@BioNTech_Group n'a pas encore tweeté.

Le chargement semble prendre du temps.

Twitter est peut-être en surcapacité ou rencontre momentanément un incident. Réessayez ou rendez-vous sur la page Twitter Status pour plus d'informations.

    Vous aimerez peut-être aussi

    ·